UNH at a glance
UnitedHealth Group (UNH, SEC CIK 731766) filed its latest 10-K annual report on March 2, 2026, a 10-Q quarterly report on November 3, 2026, an 8-K current report on November 9, 2026 and Form 4 insider filings as recently as November 13, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), UnitedHealth Group (UNH) reported revenue of $447.6 billion (up 11.8% from FY2024) and net income of $12.1 billion. Diluted EPS was $13.23.
- As of September 30, 2026, 66 institutional investment managers tracked by SignalX reported holding UnitedHealth Group (UNH) shares worth $128.7 billion in 13F-HR filings.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $447.6B
- +11.8% vs prior year
- Insiders · 90 days
- 0 buys · 0 sells
- No open-market trades
- 13F holders
- 66 funds
- $128.7B · −2 vs prior quarter
- Latest 8-K
- Nov 9, 2026
- Item 5.02
AI 10-K Annual Report Analysis
Latest 10-K, fiscal year ended Dec 31, 2025
Business Overview
- Dual-segment model: UnitedHealthcare (health benefits) + Optum (health services/tech), serving payers, providers, patients, and governments
- Major leadership overhaul: new CEO (Hemsley, May 2025), CFO (DeVeydt, Sept 2025), UHC CEO (Noel, Jan 2025), and Optum CEO (Conway, May 2025); near-complete C-suite reset
- CMS premium revenue = 44% of total consolidated revenues, dominated by UnitedHealthcare Medicare & Retirement's 8.4M Medicare Advantage members
- Optum Rx managed $188B in pharmaceutical spending in 2025, including ~$87B in specialty pharma, across ~64,000 retail pharmacies
- Optum Insight backlog declined to $31.1B from $32.8B YoY; Jan 2026 realignment moved Optum Financial (~26M accounts, $27B AUM) from Optum Health into Optum Insight
Management Discussion & Analysis
- Revenue $447.6B, up 12% YoY ($47.3B increase); UnitedHealthcare +16% to $344.9B; Optum +7% to $270.6B
- Operating margin collapsed to 4.2% vs 8.1% prior year; MCR deteriorated to 89.1% vs 85.5%; net earnings margin 2.7% vs 3.6%
- Best segment: Optum Rx revenue +$21.5B to $154.7B, operating margin 4.6% vs 4.4%; worst: Optum Health swung to -0.3% operating margin from +7.4%, losing $278M vs earning $7.8B
- Operating cash flow $19.7B vs $24.2B; capex $3.6B; dividends $7.9B; buybacks $5.5B vs $9.0B prior year
- Management expects Medicare Advantage and Medicaid membership contraction in 2026; 2027 Medicare Advantage rate notice "far below" medical cost trend; $2.5B restructuring charge signals significant ongoing cost pressure
Risk Factors
- Change Healthcare cyberattack (2024) exposed protected health information/PII; recently acquired non-integrated systems flagged as heightened ongoing vulnerability
- Goodwill and intangible assets $131B = 42% of total consolidated assets; impairment risk if acquired businesses underperform assumptions
- Medicare Advantage benchmark cuts by CMS ongoing; star ratings below 4 stars disqualify plans from quality bonus payments affecting benefits competitiveness
- FTC/DOJ antitrust enforcement actions previously brought against UHG; explicitly cited as barrier to completing future strategic acquisitions
- Premium revenues from risk-based products ~80% of total consolidated revenues; small utilization rate variances cause material financial swings
AI summary of the UNH 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Sep 30, 2026
Risk Factors
- No material changes to risk factors disclosed in the 2025 10-K
- Carried-forward business risk: additional unknown or currently immaterial risks could materially adversely affect results
- Carried-forward financial risk: existing 2025 10-K risks could materially affect financial condition
- Carried-forward performance risk: existing 2025 10-K risks could materially affect future results
Management Discussion & Analysis
- Revenue $112.7B, down $467M YoY, with UnitedHealthcare down 1% and Optum down 3%
- Operating margin 5.8% vs 3.8% YoY, net earnings margin 3.6% vs 2.1%
- Best segment Optum Insight, operating margin 23.4% vs 17.3%; worst Optum Health revenue $22.9B, down 10%
- Operating cash flow $25.1B, up $6.5B; share repurchases $5.0B and dividends $6.2B
- Headwinds: elevated medical cost trends, Medicare funding pressure, Medicaid margin risk and 1.8M fewer UnitedHealthcare people served
AI summary of the UNH 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 5.02: Departure/Appointment of Directors or Principal Officers
- Madeline Bell appointed independent director effective November 3, 2026
- Board expanded its independent leadership, potentially adding healthcare operating expertise
Item EX-99.1: Item EX-99.1
- Madeline S. Bell appointed to UnitedHealth Group’s Board, effective immediately
- Former CHOP president and CEO brings four decades of pediatric healthcare and hospital leadership experience
Item 2.02: Results of Operations and Financial Condition
- Third-quarter 2026 results announced on October 13, 2026
- Press release and supplemental PDF furnished as Exhibits 99.1 and 99.2
Item EX-99.1: Item EX-99.1
- Q3 revenue $112.7B, down from $113.2B, while operating earnings rose to $6.6B from $4.3B
- Adjusted EPS $4.69, with full-year 2026 outlook raised to at least $20.50
Item EX-99.2: Item EX-99.2
- Q3 2026 revenue $112.7B, down from $113.2B, while operating earnings rose to $6.6B from $4.3B
- Adjusted EPS $4.69 versus $2.92, supported by medical care ratio improvement to 88.4% from 89.9%
Item 7.01: Regulation FD Disclosure
- Senior leaders to discuss strategy, market positions, recent results and end-market expectations
- Wells Fargo 21st Annual Healthcare Conference, September 9, 2026 at 8:00 a.m. Eastern Time
AI summaries of UNH 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for UNH
Don't miss the next UNH filing
- Alerts as it files. A push when UNH files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut UNH, by share count.
- Ask anything. An AI agent that reads every UNH filing and answers with sources.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Noel Timothy John | F | Nov 11, 2026 | 586.536 | $402.94 |
| Gil Kristen | A | Oct 1, 2026 | 240 | - |
| MCNABB FREDERICK WILLIAM III | A | Oct 1, 2026 | 291 | - |
| FLYNN TIMOTHY PATRICK | A | Oct 1, 2026 | 262 | - |
| MONTGOMERY RICE VALERIE MD | A | Oct 1, 2026 | 257 | - |
| Gottlieb Scott | A | Oct 1, 2026 | 257 | - |
| GARCIA PAUL R | A | Oct 1, 2026 | 155 | - |
| Noseworthy John H | A | Oct 1, 2026 | 240 | - |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | - | $400.3B | $447.6B |
| Operating Income | $32.4B | $32.3B | $19.0B |
| Net Income | $22.4B | $14.4B | $12.1B |
| Op. Margin | - | 8.1% | 4.2% |
| Net Margin | - | 3.6% | 2.7% |
| Balance Sheet | |||
| Total Assets | - | $298.3B | $309.6B |
| Equity | - | $98.3B | $100.1B |
| ROE | - | 14.7% | 12.0% |
| Per Share | |||
| EPS | - | $15.51 | $13.23 |
| Cash Flow | |||
| Operating CF | $29.1B | $24.2B | $19.7B |
| CapEx | $3.4B | $3.5B | $3.6B |
Source: XBRL data in UnitedHealth Group (UNH)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q3 2026Aggregate UNH share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q3 2026 | 66 | $128.71B |
| Q2 2026 | 68 | $155.43B |
| Q1 2026 | 66 | $94.74B |
| Q4 2025 | 68 | $124.77B |
| Q3 2025 | 69 | $137.20B |
| Q2 2025 | 70 | $120.13B |
| Q1 2025 | 67 | $153.23B |
| Q4 2024 | 66 | $116.62B |
- Renaissance Technologies LLC+1.86M (+507%)
- Franklin Resources+1.77M (+21%)
- Goldman Sachs Group+1.23M (+18%)
- Citadel Advisors LLC+971.1K (+91%)
- Invesco Ltd+940.1K (+14%)
- JPMorgan Chase & Co−2.63M (-13%)
- T. Rowe Price Group−979.9K (-4%)
- Bank of America Corp−951.5K (-10%)
- Vanguard Capital Management LLC−554.1K (-1%)
- BNY Mellon−409.8K (-4%)
- FMR LLC (Fidelity)−27.99M
- Equitable Holdings Inc−32.3K
Source: 13F-HR filings on SEC EDGAR (aggregated from 540 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
UNH filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-K annual reports
10-Q quarterly reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 4 | Nov 13, 2026 | - | - | - |
| 8-K | Nov 9, 2026 | - | Analysis | - |
| 10-Q | Nov 3, 2026 | Sep 30, 2026 | Analysis | |
| 8-K | Oct 13, 2026 | - | Analysis | - |
| 4 | Oct 5, 2026 | - | - | - |
| 4 | Oct 5, 2026 | - | - | - |
| 4 | Oct 5, 2026 | - | - | - |
| 4 | Oct 5, 2026 | - | - | - |
| 4 | Oct 5, 2026 | - | - | - |
| 4 | Oct 5, 2026 | - | - | - |
| 4 | Oct 5, 2026 | - | - | - |
| 4 | Oct 5, 2026 | - | - | - |
| 4 | Sep 24, 2026 | - | - | - |
| 4 | Sep 24, 2026 | - | - | - |
| 4 | Sep 24, 2026 | - | - | - |
| 4 | Sep 24, 2026 | - | - | - |
| 4 | Sep 24, 2026 | - | - | - |
| 4 | Sep 24, 2026 | - | - | - |
| 4 | Sep 24, 2026 | - | - | - |
| 4 | Sep 24, 2026 | - | - | - |
| 4 | Sep 24, 2026 | - | - | - |
| 4 | Sep 24, 2026 | - | - | - |
| 4 | Sep 24, 2026 | - | - | - |
| 4 | Sep 24, 2026 | - | - | - |
| 4 | Sep 24, 2026 | - | - | - |
Related Health Care companies
- ALHC · Alignment Healthcare, Inc.Hospital & Medical Service Plans
- CNC · Centene CorporationHospital & Medical Service Plans
- CI · CignaHospital & Medical Service Plans
- CLOV · CLOVER HEALTH INVESTMENTS, CORP. /DEHospital & Medical Service Plans
- ELV · Elevance HealthHospital & Medical Service Plans
- HUM · HumanaHospital & Medical Service Plans
- MOH · Molina HealthcareHospital & Medical Service Plans
- OSCR · Oscar Health, Inc.Hospital & Medical Service Plans
UNH SEC filings: frequently asked questions
Which institutions hold UNH stock?
As of September 30, 2026, the largest UnitedHealth Group (UNH) holders among the 13F filers tracked by SignalX were BlackRock ($28.3 billion), Vanguard Capital Management LLC ($21.6 billion), State Street Corp ($16.8 billion), Vanguard Portfolio Management LLC ($9.0 billion), T. Rowe Price Group ($8.1 billion). 13F-HR reports are filed up to 45 days after each quarter ends.
What was UNH's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), UnitedHealth Group (UNH) reported revenue of $447.6 billion (up 11.8% from FY2024) and net income of $12.1 billion. Diluted EPS was $13.23. The figures come from the XBRL data in the 10-K.
What are the main risks in UNH's latest 10-K?
In the 10-K filed March 2, 2026, UnitedHealth Group (UNH) flagged: Change Healthcare cyberattack (2024) exposed protected health information/PII; recently acquired non-integrated systems flagged as heightened ongoing vulnerability. Goodwill and intangible assets $131B = 42% of total consolidated assets; impairment risk if acquired businesses underperform assumptions. (AI summary of the Risk Factors section.)
What did UNH report in its latest 8-K?
UnitedHealth Group (UNH) filed an 8-K on November 9, 2026 reporting Item 5.02 (Departure/Appointment of Directors or Principal Officers). Madeline Bell appointed independent director effective November 3, 2026.
What are the latest UNH SEC filings?
UnitedHealth Group (UNH) filed its latest 10-K annual report on March 2, 2026, a 10-Q quarterly report on November 3, 2026, an 8-K current report on November 9, 2026 and a Form 4 insider filing on November 13, 2026.
What is UNH's SEC CIK number?
UnitedHealth Group (UNH)'s SEC Central Index Key (CIK) is 731766. EDGAR lists every UNH filing under that number.
Ask anything about UNH
The research agent reads UNH's filings, financials, insider trades and 13F holders, then answers with sources.